Literature DB >> 1419620

Prognostic factors in breast cancer.

W R Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1419620      PMCID： PMC1977966          DOI： 10.1038/bjc.1992.358

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry.

Authors:  S M O'Reilly; R S Camplejohn; D M Barnes; R R Millis; R D Rubens; M A Richards
Journal:  J Clin Oncol       Date:  1990-12       Impact factor: 44.544

Review 2.  Is DNA flow cytometry a useful investigation in breast cancer?

Authors:  S M O'Reilly; M A Richards
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

3.  Breast cancer prognostic factors: evaluation guidelines.

Authors:  W L McGuire
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

Review 4.  Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.

Authors:  D E Merkel; W L McGuire
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

Review 5.  Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast.

Authors:  H F Frierson
Journal:  Am J Surg Pathol       Date:  1991-04       Impact factor: 6.394

6.  Different opinions on classification of DNA histograms produced from paraffin-embedded tissue.

Authors:  H Joensuu; O P Kallioniemi
Journal:  Cytometry       Date:  1989-11

7.  Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.

Authors:  G M Clark; M C Mathieu; M A Owens; L G Dressler; L Eudey; D C Tormey; C K Osborne; K W Gilchrist; E G Mansour; M D Abeloff
Journal:  J Clin Oncol       Date:  1992-03       Impact factor: 44.544
  7 in total
  2 in total

1.  Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors.

Authors:  K Szepeshazi; A V Schally; G Halmos; B Szoke; K Groot; A Nagy
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.

Authors:  P Bevilacqua; P Verderio; M Barbareschi; E Bonoldi; P Boracchi; P Dalla Palma; G Gasparini
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.